CCR5 as Target for HIV-1 Gene Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1875-5631|8|4|264-272

ISSN： 1566-5232

Source： Current Gene Therapy, Vol.8, Iss.4, 2008-08, pp. : 264-272

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CCR5 inhibitors in HIV-1 therapy

By Dorr Patrick   Perros Manos  

Expert Opinion on Drug Discovery, Vol. 3, Iss. 11, 2008-11 ,pp. : 1345-1361

Informa Healthcare

Access to resources Recommend Favorite

The CCL2/CCR2 Axis in the Pathogenesis of HIV-1 Infection: A New Cellular Target for Therapy?

By  

Current Drug Targets, Vol. 17, Iss. 1, 2016-01 ,pp. : 76-110

Bentham Science Publishers

Access to resources Recommend Favorite

CCR5 Chemokine Receptors: Gatekeepers of HIV-1 Infection

By  

Current Drug Targets - Infectious Disorders, Vol. 2, Iss. 3, 2002-09 ,pp. : 265-278

Bentham Science Publishers

Access to resources Recommend Favorite

CCR5 antagonists for the treatment of HIV

By Schmitz Jens  

PHARMAKON, Vol. 2, Iss. 4, 2014-07 ,pp. : 277-282

Govi-Verlag

Access to resources Recommend Favorite

The HIV-1 Nef protein as a target for antiretroviral therapy

By Coleman S.H.   Day J.R.   Guatelli J.C.  

Expert Opinion on Therapeutic Targets, Vol. 5, Iss. 1, 2001-02 ,pp. : 1-22

Informa Healthcare

Access to resources Recommend Favorite